Journal profile · PHARMACOLOGY & PHARMACY
Pharmaceutical Sciences
ISSN 1735-403X · eISSN 2383-2886 · Tabriz University of Medical Sciences · Iran, Islamic Republic of
Pharmaceutical Sciences: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; no APC; median 103 days to acceptance (70 articles, last 24 months); 38 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Pharmaceutical Sciences is published by Tabriz University of Medical Sciences and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Essential Oils and Antimicrobial Activity, Computational Drug Discovery Methods and Phytochemistry and Biological Activities, together about 24.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Pharmaceutical Sciences provides a forum for the publication of original research articles, reviews, short communications, and editorials (by invitation only) in all areas of pharmaceutical sciences, including these topics: Clinical Pharmacy Medicinal and Pharmaceutical Chemistry Pharmaceutical Analysis Pharmaceutics Pharmacognosy Pharmacology and Toxicology Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmacoeconomy Radiopharmacy Water, Food, Drug and Cosmetic Control
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences8.3%
- Computational Drug Discovery MethodsComputer Science7.9%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences7.9%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.4%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.8%
- Phytochemicals and Antioxidant ActivitiesMedicine5.5%
- Analytical Chemistry and ChromatographyChemistry5.5%
- Crystallization and Solubility StudiesMaterials Science5.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceEmbaseCASPublisher website
Other: Google Scholar, ProQuest, J-Gate, SCImago
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 3.1LetPub ·
- SJR 2026-06
- 0.28LetPub ·
- SNIP 2026-06
- 0.44LetPub ·
- h-index
- 31OpenAlex ·
- i10-index
- 172OpenAlex ·
- 2-year mean citedness
- 1.72OpenAlex ·
- Self-citation rate
- 5.6%LetPub ·
- Share of gold OA articles
- 99.25%LetPub ·
Volume
- Articles per year
- 44LetPub ·
Articles by year OpenAlex count · 752 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 30 | 30 | 10 |
| 2025 | 38 | 38 | 37 |
| 2024 | 41 | 41 | 141 |
| 2023 | 23 | 23 | 102 |
| 2022 | 49 | 49 | 209 |
| 2021 | 81 | 81 | 418 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
103 daysMedian, submission to acceptance · P25–P75 67 days – 150 days
- Acceptance to online
- median 91 days (70 articles)
- Submission to online
- median 217 days
- Sample
- 70 articles with submission and acceptance dates (75 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 4 weeksLetPub ·
- First decision after review
- 14 daysPublisher website ·
- Peer review
- Double anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 350 words
- Keywords
- ≥ 3
- Suggested reviewers
- Optional
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted9
- commentaryCommentary: Comments or concerns on specific subjects; overall or pertaining to items published in the journal. Also, new or additional findings of original nat…Length not stated
- editorialEditorial: The Journal’s editors or top researchers in pharmaceutical sciences (invitation by editor) write the editorial.Length not stated
- editorialsPharmaceutical Sciences provides a forum for the publication of original research articles, reviews, short communications, and editorials (by invitation only) i…Length not stated
- original articleOriginal article: Original work resulting from research, constituting complete studies that contain all relevant information.Length not stated
- original research articlesPharmaceutical Sciences provides a forum for the publication of original research articles, reviews, short communications, and editorials (by invitation only) i…Length not stated
- reviewReview: Narrative reviews or systematic review and/or meta-analysis on pharmaceutical sciences relevant topics.Length not stated
- reviewsPharmaceutical Sciences provides a forum for the publication of original research articles, reviews, short communications, and editorials (by invitation only) i…Length not stated
- short communicationShort communication: Original work, but less substantial than the regular research article, presenting preliminary results, or results of immediate relevance.Length not stated
- short communicationsPharmaceutical Sciences provides a forum for the publication of original research articles, reviews, short communications, and editorials (by invitation only) i…Length not stated
Policy excerpts from the journal's websiteConflicts of interest, License & copyright, Open access, Peer review, Plagiarism
- Conflicts of interest Competing interests
Competing interests Model summary
All authors must declare all competing interests in their covering letter and in the “competing interests” section upon submission. Where authors have no competing interests, the statement should read “The author(s) declare(s) that they have no competing interests with regards to authorship and/or publication of this article.” The Editor may ask for further information relating to competing intere…
Source ↗Publisher website ·- License & copyright
CC-BY-NC license, authors retain copyright Model summary
The authors retain the copyright to their work without restrictions, licensing under the Creative Commons license 4.0 (CC-BY-NC).
Source ↗Publisher website ·- Open access Open Access and charges
No submission or publication charges Model summary
All articles published by Pharmaceutical Sciences are made free, permanent, immediate and online availability upon publication. The authors are required to sign an exclusive license form for open access publication of their work in the journal under the Creative Commons license 4.0 (CC-BY-NC). The authors retain the copyright to their work. Free of charge publication: Currently, there are no publi…
Source ↗Publisher website ·- Peer review Peer review
Double-blind peer review process Model summary
All research articles, and most other article types, published by Pharmaceutical Sciences undergo a thorough double-blind peer review process. This usually involves review by two independent peer reviewers. The following scheme illustrates the editorial workflow ofPharmaceutical Sciences: Journal History Pharmaceutical Sciences continues the title published from 1994 to 2012 in Persian (Ulum-i Dar…
Source ↗Publisher website ·- Plagiarism
iThenticate plagiarism software Model summary
We use iThenticate software in the processing of the submissions.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Tabriz University of Medical Sciences
- Country or region
- Iran, Islamic Republic of
- Language
- English
- ISSN
- 1735-403X
- Electronic ISSN
- 2383-2886
- Society / sponsor
- Faculty of Pharmacy
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Pharmaceutical Sciences
What CAS zone is Pharmaceutical Sciences in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pharmaceutical Sciences is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Pharmaceutical Sciences?
Based on the dates recorded on 70 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 103 days (interquartile range 67–150 days); authors report an average review time of about 4 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pharmaceutical Sciences?
According to the journal's author guidelines: Abstract: ≤ 350 words; Keywords: ≥ 3; Suggested reviewers: Optional; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Pharmaceutical Sciences?
According to LetPub and DOAJ records, Pharmaceutical Sciences is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science, Embase and CAS; that list has not been checked against each database.
Is Pharmaceutical Sciences open access, and what is the APC?
Pharmaceutical Sciences is a fully open-access journal. It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .